75 related articles for article (PubMed ID: 7130773)
1. [Clinicopathological study of ovarian embryonal carcinoma (Higuchi-Kato)].
Tanaka Y; Ueda G; Yamasaki M; Inoue M; Hiramatsu K; Inoue Y; Kurachi K
Nihon Sanka Fujinka Gakkai Zasshi; 1982 Sep; 34(9):1511-8. PubMed ID: 7130773
[TBL] [Abstract][Full Text] [Related]
2. [Embryonal carcinoma (Higuchi, Kato) of the ovary, clinical analysis and recent improvement of treatment using alpha FP as a tumor marker].
Ohta M; Kano T; Nishida Y; Sakakibara K; Tomoda Y; Miyazaki T; Arii Y; Kazeto S; Iida S; Umemura S
Nihon Sanka Fujinka Gakkai Zasshi; 1986 Jun; 38(6):887-95. PubMed ID: 2426376
[TBL] [Abstract][Full Text] [Related]
3. [A case of ovarian germ cell tumor].
Hayase R; Tamada T; Tao Y; Kohno I; Kudo T; Sekiba K
Gan To Kagaku Ryoho; 1989 Aug; 16(8 Pt 1):2655-8. PubMed ID: 2476076
[TBL] [Abstract][Full Text] [Related]
4. [Four cases of embryonal carcinoma (Higuchi-Kato) of the ovary].
Kaneko N; Oda T; Fujimori K; Kimura K; Hiroi M; Matsuda M; Imai Y
Nihon Sanka Fujinka Gakkai Zasshi; 1984 Feb; 36(2):328-31. PubMed ID: 6321618
[No Abstract] [Full Text] [Related]
5. Retrospective analysis of 67 consecutive cases of pure ovarian immature teratoma.
Li H; Hong W; Zhang R; Wu L; Liu L; Zhang W
Chin Med J (Engl); 2002 Oct; 115(10):1496-500. PubMed ID: 12490095
[TBL] [Abstract][Full Text] [Related]
6. Teratoma with malignant transformation: experiences of the cooperative GPOH protocols MAKEI 83/86/89/96.
Biskup W; Calaminus G; Schneider DT; Leuschner I; Göbel U
Klin Padiatr; 2006; 218(6):303-8. PubMed ID: 17080331
[TBL] [Abstract][Full Text] [Related]
7. [Characteristics of rare ovarian tumors--possibilities of organ preservation].
Grischke EM; Wallwiener D; Bastert G
Zentralbl Gynakol; 1996; 118(6):322-5. PubMed ID: 8768007
[TBL] [Abstract][Full Text] [Related]
8. Is adjuvant chemotherapy indicated in stage I pure immature ovarian teratoma (IT)? A multicentre Italian trial in ovarian cancer (MITO-9).
Mangili G; Scarfone G; Gadducci A; Sigismondi C; Ferrandina G; Scibilia G; Viganò R; Tateo S; Villa A; Lorusso D
Gynecol Oncol; 2010 Oct; 119(1):48-52. PubMed ID: 20599258
[TBL] [Abstract][Full Text] [Related]
9. [Clinicopathological study of malignant ovarian germ cell tumor].
Kataoka A; Yakushiji M; Nishida T; Oda T; Kojiro M
Nihon Sanka Fujinka Gakkai Zasshi; 1989 Jun; 41(6):695-701. PubMed ID: 2549132
[TBL] [Abstract][Full Text] [Related]
10. [Malignant ovarian germ cell tumours: a trial of 36 cases].
Gueye A; Narducci F; Baranzelli MC; Collinet P; Farine O; Fournier C; Vinatier D; Leblanc E
Gynecol Obstet Fertil; 2007 May; 35(5):406-19. PubMed ID: 17350873
[TBL] [Abstract][Full Text] [Related]
11. Morphologic, immunohistochemical, and fluorescence in situ hybridization study of ovarian embryonal carcinoma with comparison to solid variant of yolk sac tumor and immature teratoma.
Cheng L; Zhang S; Talerman A; Roth LM
Hum Pathol; 2010 May; 41(5):716-23. PubMed ID: 20096442
[TBL] [Abstract][Full Text] [Related]
12. [BEP/VIP in children and adolescents with malignant non-testicular germ cell tumors. A comparison of the results of treatment of therapy studies MAKEI 83/86 and 89P/89].
Göbel U; Calaminus G; Teske C; Bamberg M; Bökkerink JP; Haas RJ; Holschneider AM; Janka-Schaub G; Jürgens H; Mittler U
Klin Padiatr; 1993; 205(4):231-40. PubMed ID: 7690864
[TBL] [Abstract][Full Text] [Related]
13. Immature teratoma of the ovary.
Gershenson DM; del Junco G; Silva EG; Copeland LJ; Wharton JT; Rutledge FN
Obstet Gynecol; 1986 Nov; 68(5):624-9. PubMed ID: 3763073
[TBL] [Abstract][Full Text] [Related]
14. Germ cell tumors of the gonads: a selective review emphasizing problems in differential diagnosis, newly appreciated, and controversial issues.
Ulbright TM
Mod Pathol; 2005 Feb; 18 Suppl 2():S61-79. PubMed ID: 15761467
[TBL] [Abstract][Full Text] [Related]
15. Gamma mode of infiltration associated with poor prognosis in malignant teratoma of the ovary: A case report.
Spannuth WA; Rocconi RP; Kirby TO; Huh WK; Conner MG
Gynecol Oncol; 2005 Jul; 98(1):155-7. PubMed ID: 15922442
[TBL] [Abstract][Full Text] [Related]
16. [An analysis of factors influential in improving the survival rate of patients with ovarian cancer].
Ohta M; Tomoda Y; Kano T
Gan To Kagaku Ryoho; 1989 Apr; 16(4 Pt 2-1):1008-15. PubMed ID: 2730004
[TBL] [Abstract][Full Text] [Related]
17. Nondysgerminomatous ovarian tumors: clinical characteristics, treatment, and outcome. A case-controlled study.
Ghaemmaghami F; Hasanzadeh M; Karimi Zarchi M; Fallahi A
Int J Surg; 2008 Oct; 6(5):382-6. PubMed ID: 18715834
[TBL] [Abstract][Full Text] [Related]
18. Ovarian tumors in children and adolescents less than 20 years age.
Yakushiji M; Matsukuma T; Abe M; Nishida T; Nishimura H; Tsunawaki A; Kato T
Acta Obstet Gynaecol Jpn; 1981 Jun; 33(6):833-8. PubMed ID: 7246071
[TBL] [Abstract][Full Text] [Related]
19. [Long-term follow-up of the ovarian malignant teratoma].
Zhu GZ
Zhonghua Fu Chan Ke Za Zhi; 1993 Apr; 28(4):220-3, 253-4. PubMed ID: 8404306
[TBL] [Abstract][Full Text] [Related]
20. Malignant mixed germ cell tumors of the ovary. A clinical and pathologic analysis of 30 cases.
Kurman RJ; Norris HJ
Obstet Gynecol; 1976 Nov; 48(5):579-89. PubMed ID: 185553
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
